Recombinant Human Brain Natriuretic Peptide

DRUG4 trials

Sponsors

Shanghai Renji Hospital, Shanghai Zhongshan Hospital, Shengjing Hospital, The First Affiliated Hospital with Nanjing Medical University

Conditions

Group 3 Pulmonary HypertensionMyocardial Infarction, Anterior WallSTEMISepsisVentricular Remodeling

Phase 4

Effects of intravenous human brain natriuretic peptide as an adjunct to primary angiography in acute myocardial infarction: a prospective, randomized, double-blind, placebo-controlled clinical trial

Active, not recruitingChiCTR-TRC-08000070

Shanghai Renji HospitalSTEMI

Start: 2008-04-01Updated: 2017-04-18

rhBNP in Type 3 Pulmonary Hypertension

Shengjing HospitalGroup 3 Pulmonary Hypertension

Start: 2023-04-15End: 2024-03-30Target: 72Updated: 2023-10-10

Unknown Phase

Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

Shanghai Zhongshan HospitalSepsis

Start: 2021-12-01End: 2023-12-01Target: 70Updated: 2021-11-08

Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

RecruitingNCT06463808

The First Affiliated Hospital with Nanjing Medical UniversityMyocardial Infarction, Anterior Wall, Ventricular Remodeling

Start: 2023-05-03End: 2025-02-28Target: 100Updated: 2024-06-18